VARIABILITY OF OSP GENES AND GENE-PRODUCTS AMONG SPECIES OF LYME-DISEASE SPIROCHETES

Citation
Rt. Marconi et al., VARIABILITY OF OSP GENES AND GENE-PRODUCTS AMONG SPECIES OF LYME-DISEASE SPIROCHETES, Infection and immunity, 61(6), 1993, pp. 2611-2617
Citations number
40
Categorie Soggetti
Immunology,"Infectious Diseases
Journal title
ISSN journal
00199567
Volume
61
Issue
6
Year of publication
1993
Pages
2611 - 2617
Database
ISI
SICI code
0019-9567(1993)61:6<2611:VOOGAG>2.0.ZU;2-F
Abstract
A comparison of the osp operon in 24 Lyme disease isolates, including representatives from each of the three established species, Borrellia burgdorferi, Borrelia garinii, and group VS461, was conducted. Several properties were assessed to determine whether the variability observe d in this operon was reflective of the species of the isolate. At the transcriptional level, start site and Northern (RNA) blot analyses wer e conducted. B. garinii and VS461 group isolates were found to possess an untranslated leader sequence 6 nucleotides longer than that observ ed in B. burgdorferi isolates. By Northern blot analyses all Lyme dise ase isolates, except the B. garinii isolate VS102, were found to produ ce a polycistronic full-length ospAB message. Isolate VS102 produced a truncated message lacking the ospB portion of the transcript. Souther n blot analyses suggest that the deletion occurred at the DNA level an d was not due to a posttranscriptional event. Analysis of the outer su rface proteins by two-dimensional gel electrophoresis demonstrated tha t the OspB isoelectric points were variable, with the OspB of B. garin ii isolates exhibiting a pronounced acidic shift. The reactivity of di fferent isolates to OspA and -B monoclonal antibodies and to a hyperim mune anti-ospAB serum was also variable. The results presented here de monstrate genotypic and phenotypic heterogeneity in the osp operon at both the inter- and intraspecies levels. The results have implications concerning the use of the osp genes or their gene products in the dev elopment of a Lyme disease vaccine, as diagnostic markers of Lyme dise ase, and in subtyping of Lyme disease isolates.